Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters

Cytokine

Volumn 9, Issue 8, 1997, Pages 605-612

  Sonis, S T ^a,b   Van Vugt, A G ^a   McDonald, J ^a   Dotoli, E ^a   Schwertschlag, U ^c   Szklut, P ^c   Keith, J ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

Animal model; Antineoplastics; Hamster; Interleukin 11; Mucositis

Indexed keywords

FLUOROURACIL; RECOMBINANT INTERLEUKIN 11;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CHEEK MUCOSA; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; HAMSTER; INCIDENCE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORBIDITY; MORTALITY; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

ANIMALIA; CRICETINAE;

EID: 0031213580     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0208     Document Type: Article

References (22)

1. 1. Sonis ST, Clark J (1991) Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology 5:11-16.
2. 2. Mitchell EP, Schein PS (1984) Gastrointestinal toxicity of chemotherapeutic agents. In Perry MC, Yarbo JW (eds) Toxicity of Chemotherapy, Clinical Oncology Monographs, Grune and Stratton, Orlando, pp. 269-295.
3. 3. Peterson DE (1992) Oral toxicity of chemotherapeutic agents. Semin Oncol 19:478-491.
4. 4. Caballero GA, Ausman RK, Quebbeman EJ (1985) Long-term, ambulatory continuous iv infusion of 5-FU for the treatment of advanced adenocarcinomas. Cancer Treatment Reports 69:13-15.
5. 5. Balis FM, Savitch JL, Bleyer WA, Reaman GH, Poplack DG (1985) Remission induction of meningeal leukemia with high-dose intravenous methotrexate. J. Clin Oncol 3:385-489.
6. 6. Roth BJ, Sledge GW, Williams SD, Meyer SC, Ansari R, Fisher WB (1991) Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. Cancer 68:248-252.
7. 7. Bishop JF, Joshua DE, Lowenthal RM, Kronenberg H, Whiteside MG, Coberoff R, Dodds A, Wolf M, Manoharan A (1986) A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia. Aust NZ J Med 16:48-51.
8. 8. Bergmann OJ (1989) Oral manifestations and fever in immunocompromised patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 8:207-213.
9. 9. Donnelly JP, Muus P, Horrevorts AM, Sauerwein RW, De Pauw BE (1993) Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteremia in allogeneic bone marrow recipients. Scand J Infect Dis 25:43-50.
10. 10. Sonis ST, Costa JW, Evitts SM, Lindquist LE, Nicolson M (1992) Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Path 74:749-755.
11. 11. Sonis ST, Lindquist L, Van Vugt A, Stewart AA, Stam K, Qu GY, Iwata KK, Haley JD (1994) Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta-3. Cancer Res 54:1135-1138.
12. 12. Sonis S, Muska A, O'Brien J, Van Vugt A, Langer-Safer P, Keith J (1995) Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Oral One Eur J Cane 316:261-266.
13. 13. Neben S, Turner K (1993) The biology of interleukin 11. Stem Cells 11:156-162.
14. 14. Du XX, Williams DA (1994) Interleukin-11: a multifunctional growth factor from the hematopoietic microenvironment. Blood 83:2023-2030.
15. 15. Du XX, Neben T, Goldman S, Williams DA (1993) Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood 81:27-34.
16. 16. Leonard JP, Quinto CM, Kozitza MK, Neben TY, Goldman SJ (1994) Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 83:1499-1506.
17. 17. Du XX, Doerschuk CM, Orazi A, Williams DA (1994) A bone marrow-stromal derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 83:33-37.
18. 18. Brincker H, Christensen BE (1993) Acute mucocutaneous toxicity following high-dose hydroxyurea. Cancer Chemoth Pharmacol 32:48-51.
19. 19. Lokich J, Anderson N, Bern M, Coco F, Zipoli T, Moore C, Gonsalves L (1991) Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. Cancer 68:744-746.
20. 20. Squier CA (1990) Mucosal alterations. NCI Monographs 9:169-172.
21. 21. Woo SB, Sonis ST, Monopoli MM, Sonis AL (1993) A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 72:1612-1617.
22. 22. Sonis ST, Tracey C, Shklar G, Jenson J, Florine D (1990) An animal model for mucositis induced by cancer chemotherapy. Oral Surg Oral Med Oral Path 69:437-443.